Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 2, 2006 Stephen D. Simpson	Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note.
The Motley Fool February 21, 2007 Rich Duprey	Foolish Forecast: Adding to Integra LifeSciences The med-tech company is set to report fourth-quarter 2006 earnings. Investors, here is what you can expect to see.
The Motley Fool October 31, 2005 Stephen D. Simpson	Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so.
The Motley Fool March 6, 2006 Stephen D. Simpson	Integra Integrates Higher Revenue High rewards will match high expectations -- if the medical device company delivers. Investors, take note.
The Motley Fool July 26, 2005 Stephen D. Simpson	More of the Same at Rent-A-Center Smaller rivals continue to surpass this leading rent-to-own company. Investors, take note.
The Motley Fool October 11, 2005 Stephen D. Simpson	Good Wood A commitment to upgrade the quality of business is slowing sales but sparking solid earnings performance at Universal Forest Products. Investors, take note.
The Motley Fool July 3, 2006 Stephen D. Simpson	Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note.
The Motley Fool October 12, 2005 W.D. Crotty	A Quarter That's Hard to Rectify Power management company International Rectifier forecasts a first quarter that will miss guidance. I wouldn't call Wall Street wrong for discounting this company.
The Motley Fool May 5, 2006 Stephen D. Simpson	FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock.
The Motley Fool July 27, 2005 Stephen D. Simpson	Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note.
The Motley Fool October 31, 2011 Travis Hoium	Integra LifeSciences Shares Dropped: What You Need to Know Shares of medical device maker Integra LifeSciences fell 14% today after the company released earnings and cut its full-year forecast.
The Motley Fool August 26, 2005 Stephen D. Simpson	OmniVision's Margins of Error Can this semiconductor firm's projected strong revenue growth combat sagging margins? Investors, take note.
The Motley Fool March 6, 2006 Stephen D. Simpson	Integrating Integra's Numbers: Fool by Numbers Integra LifeSciences released fourth-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool August 21, 2006 Stephen D. Simpson	Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence.
The Motley Fool February 26, 2004 Dave Marino-Nachison	Engineered Support's System Solid profit margins and successful acquisitions are helping the military contractor grow.
The Motley Fool July 28, 2005 Mike Cianciolo	Stanley Works Acquires Its Way to Growth The nation's leading toolmaker continues to build solid growth. The company projects full-year earnings of $3.20 to $3.30 per diluted share, which would represent an increase of 12% to 16% over last year's earnings.
The Motley Fool April 28, 2005 Mike Cianciolo	Stanley Hammers Away Stanley Works powers ahead with record earnings and sales. Assuming it can improve margins a bit, this stock has a lot to offer investors.
The Motley Fool January 6, 2012 Sean Williams	Integra LifeSciences Shares Plunged: What You Need to Know Shareholders of medical device maker Integra LifeSciences are falling off their second cliff in as many quarters, down 17%, after the company issued disappointing preliminary fourth-quarter and full-year guidance.
InternetNews October 14, 2004 Paul Shread	Juniper Investors Turn Picky Juniper Networks beat estimates and raised guidance after the close on Thursday... Stocks fell sharply during the day on a GM earnings miss... The Nasdaq lost 17 to 1903... etc.
The Motley Fool July 27, 2011	Integra LifeSciences Holdings Earnings Preview Integra LifeSciences Holdings will unveil its latest earnings Thursday.
The Motley Fool May 8, 2006 Stephen D. Simpson	A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company.
The Motley Fool August 3, 2006 Stephen D. Simpson	Asymmetrical Medical It may pay for investors to be patient with this med-tech company while the industry is in a rough patch.
The Motley Fool May 25, 2006 Stephen D. Simpson	Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business.
The Motley Fool March 15, 2006 Rich Smith	Foolish Forecast: New York, New Year Analysts are looking for clothier New York & Co. to hit the top of its latest guidance of $0.33 to $0.36 per share for the quarter. That 9% increase might be a bit optimistic, however, in light of the already confirmed "revenue miss."
The Motley Fool January 30, 2006 Stephen D. Simpson	Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea.
The Motley Fool April 25, 2006 Stephen D. Simpson	Kinetic Energy Although Kinetic Concepts' key patent trial has yet to begin, the stock of this wound-care specialist has been lurching up as investors apparently get a little more comfortable with the risk-reward tradeoff.
The Motley Fool October 21, 2004 Rich Duprey	K2 Slays the Competition Sporting goods manufacturer reports soaring sales, profits, and margins.
The Motley Fool August 23, 2006 Stephen D. Simpson	Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution.
The Motley Fool August 17, 2006	Comparing Companies Evaluate your investment candidates carefully -- here's how to start.
The Motley Fool November 11, 2008 Brian Orelli	AOB Is A-OK Growing through acquisitions seems to be working.
The Motley Fool November 3, 2006 Matthew Crews	Integra's Value of Growth Whenever a company earns less than its cost of capital, it destroys value. No amount of adjustments can hide the simple fact that Integra is unable to create value for its shareholders.
The Motley Fool October 19, 2005 Stephen D. Simpson	ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note.
The Motley Fool July 11, 2006 Anders Bylund	Audiovox More Bark Than Bite The electronics company is delivering on its strategy only in the narrowest sense. Investors may be better off with some of the larger competitors, which have all shown a better ability to manage pricing and margins.
The Motley Fool May 19, 2009 Brian Orelli	Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance.
The Motley Fool July 26, 2006 Stephen D. Simpson	Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow.
The Motley Fool November 3, 2006	Integra's Improving Revenues: Fool by Numbers Integra LifeSciences released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool November 13, 2006 Anders Bylund	Foolish Forecast: Tyco Still Ticking The diversified manufacturing and service company is set to report fourth-quarter and full-year earnings. Investors, here is a primer on the company and its current outlook.
The Motley Fool June 9, 2005 Richard Gibbons	Buying on Margins Profit margins are one useful tool for finding great stock values.
The Motley Fool April 20, 2006 Stephen D. Simpson	More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter.
The Motley Fool July 20, 2010 Brian Orelli	Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant.
The Motley Fool January 30, 2006 Stephen D. Simpson	Respironics in Thin Air Respironics has a great business in the sleep apnea duopoly, but it's still expensive. Investors, take note.
The Motley Fool May 4, 2006 Stephen D. Simpson	Tyco: Lots of Cash, Not Much Flash Though still a long way from operational excellence, cash flow is still solid. Investors, is there money to be made from this stock?
The Motley Fool June 27, 2005 Nathan Slaughter	Ignore Earnings Guidance Instead of searching for companies that merely sound optimistic, seek out those willing to back up that positive outlook with something more substantive than words, like dividend increases.
The Motley Fool May 27, 2011 Andrew Tonner	Does Zimmer Holdings Deserve a Spot in Your Portfolio? Compared to it's peers, Zimmer Holdings doesn't look like a stock for your portfolio right now.
The Motley Fool August 17, 2005 David Meier	The Power of Margins The way you think about margins can give you an investing edge.
The Motley Fool May 8, 2006 Stephen D. Simpson	Integra Adds Another Piece The jigsaw puzzle gets larger at Integra Lifesciences, but does it get better? Investors, this company has treated its shareholders rather well.
The Motley Fool March 9, 2005 Stephen D. Simpson	The Merits of Merit Medical Living in the gaps created by the big boys is risky for small medical device makers, but it can pay off over time. Merit Medical could hold some merit for patient value portfolios.
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
The Motley Fool July 27, 2006 Stephen D. Simpson	Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space.
The Motley Fool November 24, 2009 Brian Orelli	52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs.